Literature DB >> 33108107

RAAS Inhibitors and Risk of Covid-19. Reply.

Harmony R Reynolds1, Samrachana Adhikari1, Eduardo Iturrate1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33108107     DOI： 10.1056/NEJMc2030446

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.

Authors:  Matthew Geriak; Fadi Haddad; Ravina Kullar; Kristina L Greenwood; MacKenzie Habib; Cole Habib; David Willms; George Sakoulas
Journal:  Infect Dis Ther       Date:  2021-05-11

2.  COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.

Authors:  Yuanyuan Zhang; Mingjie Wang; Xian Zhang; Tianxiao Liu; Peter Libby; Guo-Ping Shi
Journal:  Cardiol Discov       Date:  2021-11-22

3.  Development of COVID-19 Health-Risk Assessment and Self-Evaluation (CHaSe): a health screening system for university students and staff during the movement control order (MCO).

Authors:  Azimah Ismail; Mohd Salami Ibrahim; Samhani Ismail; Azwa Abdul Aziz; Harmy Mohamed Yusoff; Mokhairi Mokhtar; Hafizan Juahir
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2022-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.